Literature DB >> 11163346

Preparation and properties of arsonolipid containing liposomes.

D Fatouros1, O Gortzi, P Klepetsanis, S G Antimisiaris, M C Stuart, A Brisson, P V Ioannou.   

Abstract

Arsonolipids are analogs of phosphonolipids which have a chemically versatile head group. In preliminary cell culture studies, liposomes composed solely of arsonolipids or of phosholipid-arsonolipid mixtures, demonstrate a specific toxicity against cancer cells (Gortzi et al., unpublished results). The possibility of using such formulations as an alternative of arsenic trioxide with or without combination of other cytostatic agents (encapsulated in their aqueous interior) prompted the investigation of their physicochemical characteristics. Herein we compared the characteristics of arsonolipid containing vesicles with different lipid compositions. Experimental results and morphological observations reveal that non-sonicated formulations have different structures and stability (when both membrane integrity and aggregation are taken into account) depending on the acyl chain length of the arsonolipid. When phospholipids and especially cholesterol are included in their membranes almost all arsonolipids studied produce more stable vesicles. An interesting aspect of these arsonolipid containing vesicles is also their negative surface charge, which may be modulated by mixing phospholipids with arsonolipids. Sonicated vesicles have smaller sizes and profoundly higher stability, especially when containing cholesterol and phosphatidylcholine mixed with arsonolipids. The only exception is that of the arsonolipid with the C(12) acyl chain which was observed to produce long tubes which break down to cubes by sonication. In conclusion, these initial studies demonstrate that sonicated vesicles composed of arsonolipid and phospholipid mixtures mixed with cholesterol posses the stability required to be used as an arsonolipid delivery system. In addition, although cryo-electron microscopy demonstrated that the sonicated vesicles are elliptical in shape, their encapsulation efficiency is not significantly lower than sonicated phospholipid liposomes. Thereby, these vesicles may be also used for the delivery of other drug molecules which can be sufficiently retained in their aqueous interior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163346     DOI: 10.1016/s0009-3084(00)00221-8

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  9 in total

1.  Arsonoliposomes for the potential treatment of medulloblastoma.

Authors:  Marco E Favretto; Showan Marouf; Panagiotis Ioannou; Sophia G Antimisiaris; Terence L Parker; Paraskevi Kallinteri
Journal:  Pharm Res       Date:  2009-07-22       Impact factor: 4.200

2.  Influence of cholesterol on liposome stability and on in vitro drug release.

Authors:  Maria-Lucia Briuglia; Chiara Rotella; Amber McFarlane; Dimitrios A Lamprou
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

3.  Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.

Authors:  Olga Gortzi; Evangelia Papadimitriou; Christos G Kontoyannis; Sophia G Antimisiaris; Panayiotis V Ioannou
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

4.  Evaluation of Extrusion Technique for Nanosizing Liposomes.

Authors:  Sandy Gim Ming Ong; Mallikarjun Chitneni; Kah Seng Lee; Long Chiau Ming; Kah Hay Yuen
Journal:  Pharmaceutics       Date:  2016-12-21       Impact factor: 6.321

5.  Multidrug Idebenone/Naproxen Co-loaded Aspasomes for Significant in vivo Anti-inflammatory Activity.

Authors:  Nicola d'Avanzo; Maria Chiara Cristiano; Luisa Di Marzio; Maria Chiara Bruno; Donatella Paolino; Christian Celia; Massimo Fresta
Journal:  ChemMedChem       Date:  2022-03-22       Impact factor: 3.540

6.  Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.

Authors:  Spyridon Mourtas; Konstantina Papadia; Golfo G Kordopati; Panayiotis V Ioannou; Sophia G Antimisiaris; Gerasimos M Tsivgoulis
Journal:  Pharmaceutics       Date:  2022-08-08       Impact factor: 6.525

7.  Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes.

Authors:  Sandy Gim Ming Ong; Long Chiau Ming; Kah Seng Lee; Kah Hay Yuen
Journal:  Pharmaceutics       Date:  2016-08-26       Impact factor: 6.321

8.  Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes.

Authors:  Paraskevi Zagana; Spyridon Mourtas; Anastasia Basta; Sophia G Antimisiaris
Journal:  Pharmaceutics       Date:  2020-04-06       Impact factor: 6.321

9.  Modified Spraying Technique and Response Surface Methodology for the Preparation and Optimization of Propolis Liposomes of Enhanced Anti-Proliferative Activity against Human Melanoma Cell Line A375.

Authors:  Hesham Refaat; Youssef W Naguib; Mahmoud M A Elsayed; Hatem A A Sarhan; Eman Alaaeldin
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.